Aenitis Technologies
Aenitis Technologies is a pioneering company specializing in acoustic-based cell manipulation and bioprocessing solutions. Their innovative platform uses acoustic levitation in flow to enable gentle, non-invasive, and precise handling of cells, which enhances yields, reduces costs, and preserves cell viability. The company develops medical devices for cell sorting, isolation, concentration, and washing, with applications spanning research, clinical, and industrial scales. Supported by a strong portfolio of patents and collaborations with research institutions and industry partners, Aenitis aims to lead in the field of bioproduction and cell therapy technologies.
Industries
Nr. of Employees
small (1-50)
Aenitis Technologies
Patents
Method and device for determining a flow rate and/or a concentration of particles of a fluid
US-12066312-B2
View DetailsClosed disposable multiple sterile blood bag system for fractionating blood with the corresponding method
US-10729828-B2
View Details
Method and device for determining a flow rate and/or a concentration of particles of a fluid
US-12066312-B2
View DetailsClosed disposable multiple sterile blood bag system for fractionating blood with the corresponding method
US-10729828-B2
View DetailsProducts
Mitis™
A flagship product based on acoustofluidic technology for cell sorting, isolation, concentration, and washing, used across research, clinical, and industrial applications.
Mitis™
A flagship product based on acoustofluidic technology for cell sorting, isolation, concentration, and washing, used across research, clinical, and industrial applications.
Services
Acoustic Cell Manipulation Devices
Development of medical devices based on acoustic radiation forces for cell handling, sorting, and filtration.
Cell Sorting and Separation Solutions
Innovative solutions for the separation, handling, and filtration of biological particles and cells using acoustophoresis.
Bioprocessing and Cell Therapy Support
Technologies aimed at improving downstream processing in cell therapy, including cell washing, concentration, and volume reduction.
Acoustic Cell Manipulation Devices
Development of medical devices based on acoustic radiation forces for cell handling, sorting, and filtration.
Cell Sorting and Separation Solutions
Innovative solutions for the separation, handling, and filtration of biological particles and cells using acoustophoresis.
Bioprocessing and Cell Therapy Support
Technologies aimed at improving downstream processing in cell therapy, including cell washing, concentration, and volume reduction.
News & Updates
Emmanuel Vincent, CEO, will attend the event in Tours, France, from March 19-20, to showcase bioproduction innovations.
CEO Emmanuel Vincent will participate in the conference in San Francisco, CA, from January 13-16, to discuss bioproduction technology advancements.
The company was highlighted for raising 6.5 million euros to develop cell sorting machines using levitation technology.
Aenitis: From Acoustic Cell Manipulation to Bioproduction Leader
An overview of Aenitis Technologies' journey, innovations, and future ambitions in cell therapy and bioprocessing.
Recognized by the French Ministry of Research and Higher Education for innovative development in medical devices.
Received funding support from Horizon 2020 for its disruptive acoustophoresis technology.
Emmanuel Vincent, CEO, will attend the event in Tours, France, from March 19-20, to showcase bioproduction innovations.
CEO Emmanuel Vincent will participate in the conference in San Francisco, CA, from January 13-16, to discuss bioproduction technology advancements.
The company was highlighted for raising 6.5 million euros to develop cell sorting machines using levitation technology.
Aenitis: From Acoustic Cell Manipulation to Bioproduction Leader
An overview of Aenitis Technologies' journey, innovations, and future ambitions in cell therapy and bioprocessing.
Recognized by the French Ministry of Research and Higher Education for innovative development in medical devices.
Received funding support from Horizon 2020 for its disruptive acoustophoresis technology.